Literature DB >> 7502074

Minimization of a polypeptide hormone.

B Li1, J Y Tom, D Oare, R Yen, W J Fairbrother, J A Wells, B C Cunningham.   

Abstract

A stepwise approach for reducing the size of a polypeptide hormone, atrial natriuretic peptide (ANP), from 28 residues to 15 while retaining high biopotency is described. Systematic structural and functional analysis identified a discontinuous functional epitope for receptor binding and activation, most of which was placed onto a smaller ring (Cys6 to Cys17) that was created by repositioning the ANP native disulfide bond (Cys7 to Cys23). High affinity was subsequently restored by optimizing the remaining noncritical residues by means of phage display. Residues that flanked the mini-ring structure were then deleted in stages, and affinity losses were rectified by additional phage-sorting experiments. Thus, structural and functional data on hormones, coupled with phage display methods, can be used to shrink the hormones to moieties more amendable to small-molecule design.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7502074     DOI: 10.1126/science.270.5242.1657

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  23 in total

Review 1.  Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity.

Authors:  A Gertler
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

2.  Binding properties of a peptide derived from beta-lactamase inhibitory protein.

Authors:  G W Rudgers; W Huang; T Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Lactam-stabilized helical analogues of the analgesic μ-conotoxin KIIIA.

Authors:  Keith K Khoo; Michael J Wilson; Brian J Smith; Min-Min Zhang; Joszef Gulyas; Doju Yoshikami; Jean E Rivier; Grzegorz Bulaj; Raymond S Norton
Journal:  J Med Chem       Date:  2011-10-12       Impact factor: 7.446

4.  Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.

Authors:  C Vita; E Drakopoulou; J Vizzavona; S Rochette; L Martin; A Ménez; C Roumestand; Y S Yang; L Ylisastigui; A Benjouad; J C Gluckman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site.

Authors:  Y A Muller; B Li; H W Christinger; J A Wells; B C Cunningham; A M de Vos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

6.  Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires.

Authors:  N Dimasi; F Martin; C Volpari; M Brunetti; G Biasiol; S Altamura; R Cortese; R De Francesco; C Steinkühler; M Sollazzo
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Two-state selection of conformation-specific antibodies.

Authors:  Junjun Gao; Sachdev S Sidhu; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

8.  Minimizing a binding domain from protein A.

Authors:  A C Braisted; J A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 9.  Minimized protein structures: a little goes a long way.

Authors:  M N Nedwidek; M H Hecht
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

10.  Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy.

Authors:  Han-Chung Wu; De-Kuan Chang
Journal:  J Oncol       Date:  2010-05-05       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.